Institution
Emory University
Education•Atlanta, Georgia, United States•
About: Emory University is a education organization based out in Atlanta, Georgia, United States. It is known for research contribution in the topics: Population & Poison control. The organization has 51959 authors who have published 122469 publications receiving 6010698 citations.
Topics: Population, Poison control, Transplantation, Health care, Cancer
Papers published on a yearly basis
Papers
More filters
••
TL;DR: The Nowicki-Strickland Locus of Control Scale appears to offer an objective, relatively precise, quick method for assessing a generalized belief in locus of control and is a significant correlate of a number of competence related behaviors in children as mentioned in this paper.
Abstract: The relationships between locus of control and other personality variables were studied, using the Nowicki-Strickland Scale. The broad hypotheses were that internal locus of control would be related to a number of other competence-type behaviors and adaptive social functioning. Results of various studies are presented, and it is concluded that the Nowicki-Strickland Locus of Control Scale appears to offer an objective, relatively precise, quick method for assessing a generalized belief in locus of control and that the locus of control dimension is a significant correlate of a number of competence related behaviors in children. (DB) Paper presented at American P5ychologica1 Association meetings, Washington, D. C., 1971 U.S. DEPARTMENT OF HEALTH. EDUCATION & WELFARE
1,620 citations
••
Boston Children's Hospital1, University of Colorado Denver2, Emory University3, Harvard University4, University of Texas at Austin5, University of Texas Southwestern Medical Center6, Cornell University7, Tulane University8, Primary Children's Hospital9, University of Pennsylvania10, University of New Mexico11, Children's Hospital Oakland Research Institute12, University of Hawaii at Manoa13, Children's Hospital of Orange County14, Oregon Health & Science University15, Children's Memorial Hospital16, Palmetto Health Richland17, Centers for Disease Control and Prevention18
TL;DR: Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A.
Abstract: Sixty-five boys younger than 30 months of age were randomly assigned to prophylaxis (32 boys) or enhanced episodic therapy (33 boys). When the boys reached 6 years of age, 93% of those in the prophylaxis group and 55% of those in the episodic-therapy group were considered to have normal index-joint structure on MRI (P = 0.006). The relative risk of MRI-detected joint damage with episodic therapy as compared with prophylaxis was 6.1 (95% confidence interval, 1.5 to 24.4). The mean annual numbers of joint and total hemorrhages were higher at study exit in the episodic-therapy group than in the prophylaxis group (P<0.001 for both comparisons). High titers of inhibitors of factor VIII developed in two boys who received prophylaxis; three boys in the episodic-therapy group had a life-threatening hemorrhage. Hospitalizations and infections associated with central-catheter placement did not differ significantly between the two groups. Conclusions Prophylaxis with recombinant factor VIII can prevent joint damage and decrease the frequency of joint and other hemorrhages in young boys with severe hemophilia A. (ClinicalTrials.gov number, NCT00207597.)
1,613 citations
••
TL;DR: Cardiac resynchronization improved quality of life, functional status, and exercise capacity in patients with moderate to severe HF, a wide QRS interval, and life-threatening arrhythmias without proarrhythmia or compromised ICD function.
Abstract: ContextCardiac resynchronization therapy (CRT) through biventricular pacing
is an effective treatment for heart failure (HF) with a wide QRS; however,
the outcomes of patients requiring CRT and implantable cardioverter defibrillator
(ICD) therapy are unknown.ObjectiveTo examine the efficacy and safety of combined CRT and ICD therapy in
patients with New York Heart Association (NYHA) class III or IV congestive
HF despite appropriate medical management.Design, Setting, and ParticipantsRandomized, double-blind, parallel-controlled trial conducted from October
1, 1999, to August 31, 2001, of 369 patients with left ventricular ejection
fraction of 35% or less, QRS duration of 130 ms, at high risk of life-threatening
ventricular arrhythmias, and in NYHA class III (n = 328) or IV (n = 41) despite
optimized medical treatment.InterventionsOf 369 randomized patients who received devices with combined CRT and
ICD capabilities, 182 were controls (ICD activated, CRT off) and 187 were
in the CRT group (ICD activated, CRT on).Main Outcome MeasuresThe primary double-blind study end points were changes between baseline
and 6 months in quality of life, functional class, and distance covered during
a 6-minute walk. Additional outcome measures included changes in exercise
capacity, plasma neurohormones, left ventricular function, and overall HF
status. Survival, incidence of ventricular arrhythmias, and rates of hospitalization
were also compared.ResultsAt 6 months, patients assigned to CRT had a greater improvement in median
(95% confidence interval) quality of life score (–17.5 [–21 to
–14] vs –11.0 [–16 to –7], P =
.02) and functional class (–1 [–1 to –1] vs 0 [–1
to 0], P = .007) than controls but were no different
in the change in distance walked in 6 minutes (55 m [44-79] vs 53 m [43-75], P = .36). Peak oxygen consumption increased by 1.1 mL/kg
per minute (0.7-1.6) in the CRT group vs 0.1 mL/kg per minute (–0.1
to 0.8) in controls (P = .04), although treadmill
exercise duration increased by 56 seconds (30-79) in the CRT group and decreased
by 11 seconds (–55 to 12) in controls (P<.001).
No significant differences were observed in changes in left ventricular size
or function, overall HF status, survival, and rates of hospitalization. No
proarrhythmia was observed and arrhythmia termination capabilities were not
impaired.ConclusionsCardiac resynchronization improved quality of life, functional status,
and exercise capacity in patients with moderate to severe HF, a wide QRS interval,
and life-threatening arrhythmias. These improvements occurred in the context
of underlying appropriate medical management without proarrhythmia or compromised
ICD function.
1,609 citations
••
Christopher J L Murray1, Ryan M Barber, Kyle J Foreman2, Ayse Abbasoglu Ozgoren +608 more•Institutions (251)
TL;DR: Patterns of the epidemiological transition with a composite indicator of sociodemographic status, which was constructed from income per person, average years of schooling after age 15 years, and the total fertility rate and mean age of the population, were quantified.
1,609 citations
••
TL;DR: An overview of the literature on medical hyperspectral imaging technology and its applications is presented, an introduction for those new to the field, an overview for those working in the field and a reference for those searching for literature on a specific application are presented.
Abstract: Hyperspectral imaging (HSI) is an emerging imaging modality for medical applications, especially in disease diagnosis and image-guided surgery. HSI acquires a three-dimensional dataset called hypercube, with two spatial dimensions and one spectral dimension. Spatially resolved spectral imaging obtained by HSI provides diagnostic information about the tissue physiology, morphology, and composition. This review paper presents an overview of the literature on medical hyperspectral imaging technology and its applications. The aim of the survey is threefold: an introduction for those new to the field, an overview for those working in the field, and a reference for those searching for literature on a specific application.
1,605 citations
Authors
Showing all 52622 results
Name | H-index | Papers | Citations |
---|---|---|---|
Younan Xia | 216 | 943 | 175757 |
Eric J. Topol | 193 | 1373 | 151025 |
Bernard Rosner | 190 | 1162 | 147661 |
Paul G. Richardson | 183 | 1533 | 155912 |
Peter W.F. Wilson | 181 | 680 | 139852 |
Dennis S. Charney | 179 | 802 | 122408 |
Joseph Biederman | 179 | 1012 | 117440 |
Kenneth C. Anderson | 178 | 1138 | 126072 |
David A. Weitz | 178 | 1038 | 114182 |
Lei Jiang | 170 | 2244 | 135205 |
William J. Sandborn | 162 | 1317 | 108564 |
Stephen J. Elledge | 162 | 406 | 112878 |
Ali H. Mokdad | 156 | 634 | 160599 |
Michael Tomasello | 155 | 797 | 93361 |
Don W. Cleveland | 152 | 444 | 84737 |